AOD-9604: What People Actually Pay

What AOD-9604 Is and Why Pricing Gets Confusing

AOD-9604 is a synthetic peptide corresponding to amino acids 176 through 191 of human growth hormone, with an added tyrosine residue. It was originally investigated for its ability to stimulate lipolysis (fat breakdown) without activating the growth hormone receptor, a property demonstrated in rodent adipose tissue by Heffernan et al. in 2001 [1]. That study showed the fragment reduced body fat in obese mice over a 19-day treatment period without altering IGF-1 levels or inducing the diabetogenic effects of full-length GH.

The peptide never completed Phase III clinical trials for obesity. No FDA-approved commercial product exists. Every vial sold in the U.S. today comes from either a 503A compounding pharmacy (patient-specific prescriptions) or a gray-market research chemical supplier. This fractured supply chain is exactly why prices swing so dramatically from one buyer to the next. A compounding pharmacy operating under state board oversight charges for pharmaceutical-grade synthesis, sterility testing, and a prescriber relationship. A research peptide vendor on the open internet charges for none of those things.

Reddit-Reported Prices: What the Forums Say

Across r/Peptides, r/Semaglutide, and r/Trt, AOD-9604 pricing discussions cluster into three tiers. Users buying from U.S. compounding pharmacies with a prescription typically report $200 to $350 per month. Those purchasing through telehealth peptide clinics (which bundle the prescription, consultation, and product) report $250 to $449 per month. And those sourcing research-grade peptides from overseas vendors report $30 to $80 per 5 mg vial, sometimes less.

One frequently cited Reddit post in r/Peptides described paying "$220/month from a 503A pharmacy in Florida for two 5 mg vials." Another user in the same thread responded that their telehealth provider charged "$399/month but that includes AOD and BPC-157 together plus monthly check-ins." These numbers are consistent with what peptide clinic websites publicly list, though pricing pages change frequently.

The self-selection problem here is real. Reddit peptide communities skew toward men aged 25 to 45 who are already comfortable with subcutaneous injections and who have tried other compounds. Their cost tolerance and sourcing sophistication do not represent the general population. The sample sizes in any given thread rarely exceed 15 to 30 respondents. No structured survey with validated methodology exists for AOD-9604 user costs.

Compounding Pharmacy Pricing Breakdown

A 503A compounding pharmacy fills AOD-9604 prescriptions on a per-patient basis after receiving a valid prescription from a licensed provider. The FDA's guidance on compounding requires these pharmacies to operate under state licensure and meet specific quality standards [2]. Prices at this tier reflect ingredient costs, sterility testing, beyond-use dating studies, and pharmacy overhead.

Typical compounding pharmacy pricing for AOD-9604 injectable:

• 5 mg lyophilized vial: $75 to $150 per vial
• Monthly supply at 300 mcg/day: 2 vials = $150 to $300
• Monthly supply at 500 mcg/day: 3 vials = $225 to $450
• Bacteriostatic water (if not included): $8 to $15

Some pharmacies offer 10 mg or 15 mg vials at a lower per-milligram cost, which brings the monthly expense down to the $175 to $250 range for standard dosing. Pricing also depends on geography. Compounding pharmacies in Texas, Florida, and California, where peptide prescribing volume is highest, tend to price more competitively than pharmacies in states with lower demand.

Dr. Ryan Smith, a board-certified physician specializing in regenerative medicine, has noted: "The cost of compounded AOD-9604 reflects quality assurance processes that research-grade suppliers simply skip. You are paying for third-party potency testing and sterility verification."

Telehealth Clinic Subscription Models

The telehealth peptide clinic model bundles prescriber access, the compounded product, and sometimes adjunctive peptides into a single monthly fee. This is the fastest-growing channel for AOD-9604 access, and it is also where pricing is least transparent.

Subscription tiers typically look like this:

• Basic (AOD-9604 only): $199 to $299/month
• Peptide stack (AOD-9604 + CJC-1295/Ipamorelin or BPC-157): $349 to $549/month
• Premium (stack + labs + monthly provider calls): $449 to $699/month

These prices include shipping in most cases. The markup over pharmacy-only pricing ranges from 30% to 100%, which covers the clinic's provider time, platform technology, and customer acquisition costs. For patients who would otherwise pay $150 to $200 for a standalone physician consultation plus $200 to $300 for the compounded peptide, the bundled model can actually reduce total out-of-pocket spend.

The Endocrine Society's position on peptide therapies emphasizes that any hormone-adjacent therapy should involve baseline and follow-up lab monitoring [3]. Clinics that skip labs to keep subscription costs low raise safety concerns, even with a peptide like AOD-9604 that does not appear to alter IGF-1 or glucose metabolism based on available animal data [1].

Gray-Market and Research-Grade Pricing

Research peptide vendors sell AOD-9604 labeled "for research use only" at dramatically lower prices. A 5 mg vial from a U.S.-based research supplier typically costs $35 to $80. International vendors, particularly those shipping from China, list prices as low as $15 to $30 per 5 mg vial, sometimes with bulk discounts dropping the per-vial cost under $10.

These prices are low because the products bypass pharmaceutical compounding standards. There is no prescriber in the loop, no patient-specific compounding, and no regulatory oversight of the final product. Third-party testing by independent researchers has repeatedly found that research-grade peptides may contain incorrect concentrations, degradation products, or bacterial endotoxins. The FDA has issued warnings about unapproved peptide products sold online [4].

The price gap is stark. A patient paying $250/month through a compounding pharmacy is spending roughly 3 to 8 times more than someone buying research-grade product. But they are also receiving a product with verified identity, potency, sterility, and a legal prescription. For a peptide injected subcutaneously, the sterility question alone carries meaningful risk.

How AOD-9604 Costs Compare to GLP-1 Agonists

Patients considering AOD-9604 for fat loss often compare its cost to GLP-1 receptor agonists like semaglutide and tirzepatide. The comparison is not straightforward because the evidence bases are vastly different.

Semaglutide 2.4 mg (Wegovy) produced 14.9% mean body weight loss at 68 weeks vs. 2.4% with placebo in the STEP-1 trial (N=1,961) [5]. AOD-9604 has no comparable human efficacy trial. Its evidence consists primarily of rodent studies and a Phase IIb trial that did not meet its primary endpoint for weight loss in humans.

On a monthly cost basis:

• Branded semaglutide (Wegovy): $1,349 list price; $300 to $550 with manufacturer savings programs
• Compounded semaglutide: $200 to $500/month (before the FDA's compounding policy changes)
• Compounded tirzepatide: $250 to $600/month
• Compounded AOD-9604: $150 to $450/month

AOD-9604 is cheaper at the low end, but the cost-per-pound-lost calculation is impossible to make because no rigorous human trial has quantified AOD-9604's weight loss effect. Patients choosing AOD-9604 over a GLP-1 agonist are making a decision based on anecdotal reports, not comparative effectiveness data.

Dr. Karl Nadolsky, a board-certified endocrinologist and obesity medicine specialist, has stated: "We have strong randomized controlled trial data for GLP-1 agonists and essentially no human efficacy data for AOD-9604. Cost should be weighed against evidence, not just price tags."

What Reddit Users Report About Results Relative to Cost

Reddit discussions about AOD-9604 results are mixed, and the relationship between reported outcomes and cost paid is not linear. Users who purchased from compounding pharmacies and those who purchased research-grade product report similar ranges of subjective outcomes, though compounding pharmacy users tend to report with more specificity about dosing protocols.

Common themes across r/Peptides and r/Trt threads include:

• "Modest" fat loss: Most users who report any effect describe 3 to 8 lbs lost over 4 to 8 weeks, though nearly all were also dieting and exercising. Isolating the peptide's contribution is impossible from self-reports.
• "Nothing happened": A meaningful subset of users, roughly 30% to 40% of those posting, report no noticeable effect after 4 to 12 weeks of use.
• Stacking confounders: Many AOD-9604 users simultaneously take other peptides (CJC-1295, Ipamorelin, BPC-157) or GLP-1 agonists, making attribution to any single compound speculative.

One r/Peptides user summarized the value proposition bluntly: "At $250/month with no proven human data, AOD is expensive for a maybe. At $40/vial research grade, it is cheap enough to try but you are injecting something with no quality guarantee."

This cost-outcome tension is the central issue for AOD-9604. The peptide sits in a pricing zone where it is too expensive to dismiss as trivial but too unproven to justify as a medical investment. Patients considering it should understand that every dollar spent is a bet on animal data and anecdotal reports, not on the kind of evidence that supports FDA-approved anti-obesity medications [6].

Hidden Costs Beyond the Peptide Itself

The sticker price for AOD-9604 vials does not capture total out-of-pocket cost. Patients new to subcutaneous peptide injection also need:

• Insulin syringes (29-31 gauge): $15 to $25 per box of 100
• Alcohol swabs: $5 to $10 per box
• Bacteriostatic water: $8 to $15 per 30 mL vial
• Sharps container: $5 to $10
• Initial provider consultation (if not bundled): $100 to $250
• Follow-up labs (if ordered): $50 to $200 depending on panel

These ancillary costs add $30 to $60 per month for supplies alone, plus $100 to $250 upfront for the initial prescriber visit at clinics that charge separately. Factoring in supplies and consultation, a first month of AOD-9604 through a non-subscription compounding pharmacy pathway could total $350 to $550, settling to $200 to $350 per month thereafter.

How to Reduce AOD-9604 Costs

Patients committed to trying AOD-9604 through legitimate channels can reduce costs in several ways. Requesting larger vial sizes (10 mg instead of 5 mg) typically reduces per-milligram cost by 15% to 30%. Some compounding pharmacies offer 90-day supplies at a 10% to 15% discount. Choosing injectable over oral or sublingual formulations avoids paying more for a delivery method with lower and more variable bioavailability.

Comparing quotes from at least three compounding pharmacies is worth the 30 minutes of effort. Pricing for the same 5 mg AOD-9604 vial can differ by $50 to $75 between pharmacies in the same state. The National Association of Boards of Pharmacy provides resources for verifying that a compounding pharmacy operates under appropriate state and federal oversight [7].

Patients should avoid "free consultation" models where the consultation cost is simply folded into an inflated product price. Transparent pricing, where the prescriber fee and the compounded product price are listed separately, generally results in lower total cost over a 3- to 6-month trial period.

Baseline fasting glucose, HbA1c, and a lipid panel before starting AOD-9604, repeated at 8 to 12 weeks, cost $50 to $150 through direct-to-consumer lab services and provide the only objective way to track whether the investment is producing measurable metabolic changes.